The CHIP assays at the proximal promoter region also show that DLL4 expression in LFS cells is mostly dysregulated when compared to the normal cell, HS27, and breast cancer cell, MCF7, possibly due to TP53 mutation or functional alterations that predispose to abnormal genetic consequences. The gene discussed is DLL4; the disease is breast carcinoma.